Please login to the form below

Behavioural insights to navigate complex healthcare markets

Blue Latitude Health Head of Insight Martine Leroy reveals how her team uses behavioural insights to help develop strong pharma brands and services, which successfully navigate complex situations.
The European Union alone spends €700bn (£624 bn) annually on chronic disease management. Healthcare systems, which were initially designed for single disease states, are now required to manage polypharmacy and to also coordinate care. This is an unprecedented challenge. Now, policymakers are developing new care ecosystems, increasingly driven by home care and patient self-management.

There are thousands of health interventions on the market designed to improve patient outcomes – most of them digital. Demand is still growing as more patients, carers and healthcare professionals find themselves navigating complex disease states. Luckily, our learning from behavioural science and its applications has progressed significantly during the last decade and there is growing evidence of what works and does not.

In pharma, our data-rich, evidence-based and technology-driven heritage allows us to translate our learning into brand initiatives that ensure we can develop our brands in complex markets and situations.

At Blue Latitude Health, we apply this novel thinking to launch excellence and service design. Here, we outline how this knowledge can help navigate complex markets, helping our clients to improve care and health outcomes, while optimising brand success.

A perfect storm

Today’s healthcare world relies on a perfect storm of scientific understanding of human behaviour, the public salience of complexity of care, and progress in artificial intelligence. Behavioural science teaches us that patients and healthcare professionals alike are fundamentally people.

Behavioural insights, captured in context, give us a detailed understanding of the true dimensions of stakeholders’ behaviours and possible implications on care.

We are all savvy, demanding, and our expectations of treatments and interventions are soaring. We expect support, digital or otherwise, to be user-friendly, fit into our lifestyles and provide ongoing feedback.

Behavioural theory uncovers true customer insights and shapes brand solutions, which are powerful tools in complex situations. For example, let’s consider the 50 million multimorbidity patients in Europe. They pose a multi-dimensional challenge, from maintaining adherence to poly-medication and managing diseases across disease states, to delivering adequate care at population, sub-group, or individual levels.

The EU-funded Horizon 2020 Digital Health Research Programme, ProAct2020 (Advancing Proactive Digital Integrated Care) aims to develop and evaluate a digital integrated care system to support older adults living with multimorbidity (multiple chronic conditions). ProAct uses behavioural insights to frame, inform and guide its work, and the power of artificial intelligence to align big and small data, ensuring the identification of appropriate care interventions. It is a live and topical pilot example of the perfect storm in action.

The BLH approach: unravelling the complexity

Pharma brands can take advantage of the behavioural insights approach to meet needs and expectations of multiple stakeholders. To do this, our Insight and Customer Experience teams use their extensive experience of behavioural change in complex situations and their deep understanding of the the power of insight to help pharma organisations develop strong brand strategies and plans in complex scenarios.

We use the 
COM-B behavioural logic model and empirical evidence from behavioural interventions to uncover the interventions that work and those that don’t.



Download the full article from Blue Latitude Health


6th June 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health
Crusader House
145-157 St John Street
London
EC1V 4QJ
United Kingdom

Latest content on this profile

Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine.
Blue Latitude Health
Behavioural insights to navigate complex healthcare markets
Blue Latitude Health Head of Insight Martine Leroy reveals how her team uses behavioural insights to help develop strong pharma brands and services, which successfully navigate complex situations.
Blue Latitude Health
Biotech: it's a people business
Nancy Hunter is the Marketing Director at a cutting-edge pharmaceutical company. Here she explains how a sharp focus on patients’ needs is driving a new operating model for marketing first-in-class drugs, and she describes how her mother’s experience as a cancer patient has shaped her own outlook on healthcare.
Blue Latitude Health
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges and opportunities while introducing the latest issue of 'Perspective' magazine on this weighty topic.
Blue Latitude Health
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively.
Blue Latitude Health
Does your medical information service work for your users?
Customer Experience Consultant Nilu Davies reveals how you can ensure your medical information service is fit for purpose.
Blue Latitude Health